Thomas Rossnagel - former head of Sunrise’s Europe business and operations has been promoted to President and CEO of Sunrise Medical. Michael N. Cannizzaro - former CEO will continue as Chairman of the Board of Directors.

Rossnagel who worked out of the companies German operations is recognised in Europe for his leadership - and his most notable performance in driving efficient and effective operations for Sunrise Europe over the past several years.

With this latest move Sunrise continues to demonstrate it’s ability to take a global management perspective to it’s business.

The full press release is here.

May

The healthcare system in France is the envy of most developed countries of the world. France is also the worlds 5th largest country in terms of GDP.

This makes the above event one of the world’s top events from a business potential for those that have an interest in the rapidly expanding healthcare sectors concerning geriatrics, disability, homecare and institutional care - as the ageing population moves from acute to chronic care.

GerontExpo-handicap provides a venue for updating on the latest technologies, products, policies and trends as well as providing significant business opportunities for either manufacturers, distributors or service providers to significantly enhance their business by finding the right business partners in France and internationally.

As a plus HIT 2009 (Health Information Technologies) - will take place in the same venue and will be linked to GerontExpo-Handicap. HIT represents the rapidly growing French Healthcare IT industry and is expected to have over 100 participating companies - large and small.

Frank Barlin - Sibaya LifeScience! Managing Partner will be attending and can be contacted here.

We strongly support diabetes research on this site so wanted to share this: (BBC)

Tighter control of blood sugar levels in people with diabetes may cut their risk of heart problems, a study says.

From the Cambridge Study (30000 patients) just published in the British Lancet the following is observed:

Lead researcher Dr Kausik Ray said: “Previous studies have been inconclusive, leaving diabetics and their doctors unsure as to whether maintaining lower blood sugar levels actually benefited the patients.

“Although additional research needs to be conducted, our findings provide insight into the importance of improving glucose levels. However, this has to be done through lifestyle changes as well as medication.”

Results were fewer heart attacks and 15% less cardi-vascular desease.

Press Release:

Biotech from Saxony-Anhalt in America

Halle (Saale) – 05.18.2009. The state of Saxony-Anhalt will participate in the world’s largest biotechnology fair, BIO International, in Atlanta, GA, USA this year.

From the 18th to the 21st of May, 2009 the state will promote new technologies from the medicinal and green biotechnology fields, with it’s own presentation within the common German booth. The trade-show appearance is a result of a collaborative effort with the Saxony-Anhalt investment and marketing corporation mbH (Investitions- und Marketinggesellschaft Sachsen-Anhalt mbH). “We are pleased that the fair’s organizers have again invited a company, namely the novosom corporation from Halle, to present and discuss its technology” commented Dr. Jens Katzek, Managing Director of BIO Middle Germany (BIO Mitteldeutschland), on the participation of the Halle-based Biotech Company novosom.
[Read more →]

press release:

Jon Sintorn has been appointed the new CEO of Permobil AB. He will take up the post on 1 September 2009. Mr Sintorn succeeds Hans Bergh who, after 20 years with the company, is leaving his position as CEO to serve on the Board of Directors.

Permobil is the global leader in advanced wheelchair solutions and has strong market positions in North America and Europe. The company is based in Timrå, Sweden and has 550 employees.

[Read more →]

ICH Q10: final guidance for implementing an effective quality management system for the pharmaceutical industry.

The FDA has just issued its final guidance on ICH Q10.

This internationally harmonized guidance is intended to assist all pharmaceutical manufacturers by describing a model for an effective quality management system called pharmaceutical quality system. Based on International Organization for Standardization (ISO) quality concepts, it includes applicable good manufacturing practice (GMP) regulations, and complements ICH “Q8 Pharmaceutical Development” and ICH “Q9 Quality Risk Management.”

Interestingly, this model can be implemented throughout the different stages of a product lifecycle and strengthen the link between pharmaceutical development, manufacturing and commercial activities.

It reinforces the need for Leadership which is essential to establish and maintain a company-wide commitment to quality and for the performance of the pharmaceutical quality system to achieve product realization, to establish and maintain a state of control and to facilitate continual improvement.

FDA also insists that companies use knowledge and quality risk management and apply this guidance to their outsourced activities and the purchase of raw materials while conducting assessments of suppliers and service providers before entering into an agreement.

Days Healthcare Germany - according to this announcement on their website has announced that they will be closing their German business effective end June. Days Healthcare Germany is part of the Irish multinational DCC group and was formerly known as Casacare.
[Read more →]